JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

SENP1-Mediated deSUMOylation Regulates the Tumor Remodeling of Glioma Stem Cells Under Hypoxic Stress

  • 0Department of Neurosurgery, 2nd Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Technology in Cancer Research & Treatment +

|

May 28, 2024

|

May 28, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Targeting SENP1-mediated deSUMOylation in glioma stem cells (GSCs) can suppress glioblastoma (GBM) progression. This study shows SENP1 is crucial for GBM maintenance, offering a potential therapeutic target.

Area Of Science

  • Neuro-oncology
  • Molecular Biology
  • Cellular Biology

Background

  • Hypoxia upregulates hypoxia-inducible factor 1α (HIF1α) in glioma stem cells (GSCs), activating Wnt/β-catenin signaling for glioblastoma (GBM) growth.
  • SENP1-mediated deSUMOylation stabilizes HIF1α and β-catenin, promoting GSC-driven tumorigenesis.

Purpose Of The Study

  • To investigate the role of SENP1-mediated deSUMOylation in GSC malignancy under hypoxia.
  • To evaluate SENP1 as a potential therapeutic target for GBM.

Main Methods

  • Immunohistochemistry and western blot to assess SENP1 expression in gliomas.
  • Lentivirus-mediated shRNA to downregulate SENP1 in GSCs.
  • In vitro assays (scratch, cloning) and in vivo tumor formation studies in nude mice.
  • Immunoprecipitation to elucidate the regulatory mechanism.

Main Results

  • SENP1 expression is upregulated in GBM, particularly in GSCs.
  • Hypoxia induces SENP1-mediated deSUMOylation, enhancing GSC proliferation, migration, and tumorigenesis.
  • Downregulating SENP1 attenuated GSC malignancy and GBM growth.

Conclusions

  • SENP1-mediated deSUMOylation is essential for GBM maintenance by stabilizing HIF1α and β-catenin.
  • Targeting SENP1 in GSCs presents a promising therapeutic strategy to improve GBM treatment efficacy.

Keywords: